Genematrix invested 5.7 billion won in British company, Vaccitech... “Investment for joint :new drug development cooperation” 페이지 정보 작성일 18-12-20 00:00 목록 본문 . 관련링크 https://www.paxetv.com/news/articleView.html?idxno=64359 699회 연결 Genematrix acquired a new product license from KFDA for multiplex molecular diagnosis of pneumonia causative virus 19.04.03 Neoplex product lines successively acquired 'European CE certification' 17.11.22
ENG